Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) from a hold rating to a buy rating in a research note released on Wednesday morning. Several other research analysts have also recently weighed in on the stock. Cantor Fitzgerald reissued an overweight rating and issued a $5.00 price target on shares of Cidara Therapeutics […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) saw a large increase in short interest in September. As of September 15th, there was short interest totalling 1,560,000 shares, an increase of 31.1% from the August 31st total of 1,190,000 shares. Based on an average trading volume of 608,700 shares, the days-to-cover ratio is presently 2.6 […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 1,190,000 shares, a drop of 16.2% from the August 15th total of 1,420,000 shares. Based on an average trading volume of 647,900 shares, the days-to-cover ratio […]
StockNews.com cut shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. Several other brokerages have also recently issued reports on CDTX. Needham & Company LLC reissued a buy rating and issued a $3.00 price objective on shares of […]
Needham & Company LLC restated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report report published on Friday morning, Benzinga reports. The firm currently has a $3.00 target price on the biotechnology company’s stock. CDTX has been the subject of a number of other reports. HC Wainwright reaffirmed […]